Biologics Linked to Lower Infection Risk in Older Adults With Psoriatic Disease
Older adults with psoriatic disease may face a lower risk of serious infections when treated with biologics targeting interleukin (IL)-12, IL-23, or IL-17, according to a new study.1 The study found that these biologics were associated with fewer hospitalizations for […]
Biologics Linked to Lower Infection Risk in Older Adults With Psoriatic Disease Read More »